Elixxer +C$0 +0% Tuesday 20:00
1D 1W 1M 3M 1Y 5Y
30 Sep Expected
This list is based on the watchlists of people on Stock Events who follow ELXR.V. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Canopy Growth
CGC
Mkt Cap 580.69M
Canopy Growth Corporation is a competitor because it operates in the cannabis sector, offering similar products and services as Elixxer, targeting the same market segment. Aurora Cannabis
ACB
Mkt Cap 332.34M
Aurora Cannabis is a direct competitor in the cannabis industry, producing and distributing medical marijuana products which overlap with Elixxer's offerings. Tilray Brands
TLRY
Mkt Cap 1.44B
Tilray is involved in the research, cultivation, production, and distribution of medical cannabis and cannabinoids, making it a competitor to Elixxer in the cannabis market. Cronos Group
CRON
Mkt Cap 863.96M
Cronos Group is a competitor due to its global presence in the cannabis industry, directly competing with Elixxer in several markets for both recreational and medicinal cannabis products.
Sundial Growers is involved in the production, distribution, and sale of cannabis for the adult-use market, making it a competitor to Elixxer. OrganiGram
OGI
Mkt Cap 192.03M
OrganiGram Holdings is a producer and seller of medical and recreational cannabis, directly competing with Elixxer in the cannabis market.
Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It invests in cultivation, production, and/or sale of medical cannabis and cannabis-derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. Elixxer Ltd. was incorporated in 2004 and is based in Montreal, Canada.
Show more...